Ricky  Joshi

Dr. Ricky Joshi


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JQJavier Quilez
Javier Quilez
AGAudrey Guilmatre
Audrey Guilmatre
PGParas Garg
Paras Garg
GHGareth Highnam
Gareth Highnam
MGMelissa Gymrek
Melissa Gymrek
ASAndrew J. Sharp
Andrew J. Sharp
Despite representing an important source of genetic variation, tandem repeats (TRs) remain poorly studied due to technical difficulties. We hypothesized that TRs can operate as expression (eQTLs) and methylation (mQTLs) quantitative trait loci. To test this we analyzed the effect of variation at 4849 promoter-associated TRs, genotyped in 120 individuals, on neighboring gene expression and DNA methylation. Polymorphic promoter TRs were associated with increased variance in local gene expression and DNA methylation, suggesting functional consequences related to TR variation. We identified >100 TRs associated with expression/methylation levels of adjacent genes. These potential eQTL/mQTL TRs were enriched for overlaps with transcription factor binding and DNaseI hypersensitivity sites, providing a rationale for their effects. Moreover, we showed that most TR variants are poorly tagged by nearby single nucleotide polymorphisms (SNPs) markers, indicating that many functional TR variants are not effectively assayed by SNP-based approaches. Our study assigns biological significance to TR variations in the human genome, and suggests that a significant fraction of TR variations exert functional effects via alterations of local gene expression or epigenetics. We conclude that targeted studies that focus on genotyping TR variants are required to fully ascertain functional variation in the genome.

25 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMafalda Barbosa
Mafalda Barbosa
RJRicky Joshi
Ricky Joshi
PGParas Garg
Paras Garg
AMAlejandro Martin-Trujillo
Alejandro Martin-Trujillo
NPNihir Patel
Nihir Patel
ASAndrew J. Sharp
Andrew J. Sharp
Certain human traits such as neurodevelopmental disorders (NDs) and congenital anomalies (CAs) are believed to be primarily genetic in origin. However, even after whole-genome sequencing (WGS), a substantial fraction of such disorders remain unexplained. We hypothesize that some cases of ND–CA are caused by aberrant DNA methylation leading to dysregulated genome function. Comparing DNA methylation profiles from 489 individuals with ND–CAs against 1534 controls, we identify epivariations as a frequent occurrence in the human genome. De novo epivariations are significantly enriched in cases, while RNAseq analysis shows that epivariations often have an impact on gene expression comparable to loss-of-function mutations. Additionally, we detect and replicate an enrichment of rare sequence mutations overlapping CTCF binding sites close to epivariations, providing a rationale for interpreting non-coding variation. We propose that epivariations contribute to the pathogenesis of some patients with unexplained ND–CAs, and as such likely have diagnostic relevance.

18 June 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RJRicky Joshi
Ricky Joshi
Benjamin PiñaBenjamin Piña
Benjamin Piña
JRJoaquim Roca
Joaquim Roca
The extent to which the DNA relaxation activities of eukaryotic topoisomerases (topo I and topo II) are redundant during gene transcription is unclear. Although both enzymes can often substitute for each other in vivo, studies in vitro had revealed that the DNA cross-inversion mechanism of topo II relaxes chromatin more efficiently than the DNA strand-rotation mechanism of topo I. Here, we show that the inactivation of topo II in budding yeast produces an abrupt decrease of virtually all polyA+ RNA transcripts of length above ∼3 kb, irrespective of their function. This reduction is not related to transcription initiation but to the stall of RNA polymerase II (Pol II) during elongation. This reduction does not occur in topo I mutants; and it is not avoided by overproducing yeast topo I or bacterial topo I, which relaxes (−) DNA supercoils. It is rescued by catalytically active topo II or a GyrBA enzyme, which relaxes (+) DNA supercoils. These findings demonstrate that DNA relaxation activities of topo I and topo II are not interchangeable in vivo. Apparently, only topo II relaxes efficiently the (+) DNA supercoils that stall the advancement of Pol II in long genes. A mechanistic model is proposed.

1 September 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
RJRicky Joshi
Ricky Joshi
PGParas Garg
Paras Garg
NZNoah Zaitlen
Noah Zaitlen
TLTuuli Lappalainen
Tuuli Lappalainen
CWCorey T. Watson
Corey T. Watson
ASAndrew J. Sharp
Andrew J. Sharp

1 June 2021 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
LMLeslie Matalonga
Leslie Matalonga
CHCarles Hernández-Ferrer
Carles Hernández-Ferrer
DPDavide Piscia
Davide Piscia
RSRebecca Schüle
Rebecca Schüle
MSMatthis Synofzik
Matthis Synofzik
SBSergi Beltran
Sergi Beltran
Reanalysis of inconclusive exome/genome sequencing data increases the diagnosis yield of patients with rare diseases. However, the cost and efforts required for reanalysis prevent its routine implementation in research and clinical environments. The Solve-RD project aims to reveal the molecular causes underlying undiagnosed rare diseases. One of the goals is to implement innovative approaches to reanalyse the exomes and genomes from thousands of well-studied undiagnosed cases. The raw genomic data is submitted to Solve-RD through the RD-Connect Genome-Phenome Analysis Platform (GPAP) together with standardised phenotypic and pedigree data. We have developed a programmatic workflow to reanalyse genome-phenome data. It uses the RD-Connect GPAP’s Application Programming Interface (API) and relies on the big-data technologies upon which the system is built. We have applied the workflow to prioritise rare known pathogenic variants from 4411 undiagnosed cases. The queries returned an average of 1.45 variants per case, which first were evaluated in bulk by a panel of disease experts and afterwards specifically by the submitter of each case. A total of 120 index cases (21.2% of prioritised cases, 2.7% of all exome/genome-negative samples) have already been solved, with others being under investigation. The implementation of solutions as the one described here provide the technical framework to enable periodic case-level data re-evaluation in clinical settings, as recommended by the American College of Medical Genetics.

1 October 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
PGParas Garg
Paras Garg
RJRicky Joshi
Ricky Joshi
CWCorey Watson
Corey Watson
ASAndrew J. Sharp
Andrew J. Sharp
While population studies have resulted in detailed maps of genetic variation in humans, to date there are few robust maps of epigenetic variation. We identified sites containing clusters of CpGs with high inter-individual epigenetic variation, termed Variably Methylated Regions (VMRs) in five purified cell types. We observed that VMRs occur preferentially at enhancers and 3’ UTRs. While the majority of VMRs have high heritability, a subset of VMRs within the genome show highly correlated variation in trans, forming co-regulated networks that have low heritability, differ between cell types and are enriched for specific transcription factor binding sites and biological pathways of functional relevance to each tissue. For example, in T cells we defined a network of 95 co-regulated VMRs enriched for genes with roles in T-cell activation; in fibroblasts a network of 34 co-regulated VMRs comprising all four HOX gene clusters enriched for control of tissue growth; and in neurons a network of 18 VMRs enriched for roles in synaptic signaling. By culturing genetically-identical fibroblasts under varying environmental conditions, we experimentally demonstrated that some VMR networks are responsive to the environment, with methylation levels at these loci changing in a coordinated fashion in trans dependent on cellular growth. Intriguingly these environmentally-responsive VMRs showed a strong enrichment for imprinted loci (p<10−80), suggesting that these are particularly sensitive to environmental conditions. Our study provides a detailed map of common epigenetic variation in the human genome, showing that both genetic and environmental causes underlie this variation. Multiple published studies have demonstrated that epigenetic variation can contribute to phenotypic variation. In the present study, we identified regions of common methylation variation in five cell types, observing that these show enrichments for functional genomic features. Surprisingly, we found that these epigenetic variations can form biologically relevant networks that are specific to each cell type, often occurring near genes that have functional relevance to the cell type. Further these regions show reduced heritability, suggesting they may be responsive to environmental cues. We confirmed this by subjecting isogenic fibroblast cultures to different environmental stress. Our study provides insight into patterns of normal epigenetic variation in the human population.